<DOC>
	<DOCNO>NCT02931279</DOCNO>
	<brief_summary>Prospective , multicenter non comparative observational study ( post-market clinical follow-up ) . Patients operated PASS OCT® manufacture MEDICREA® INTERNATIONAL July 2016 July 2017 . The inclusion period 12 month follow-up 24 month</brief_summary>
	<brief_title>PASS OCT® Post-market Clinical Follow-up</brief_title>
	<detailed_description>The primary endpoint evaluate safety PASS OCT® system . The secondary endpoint analyze efficacy system several point view : - The quality fusion time fusion X ray - pain VAS - quality life thanks questionnaire : NDI ( Neck Disability Index ) JOA myelopathy - daily patient : return work , sport - surgeon satisfaction .</detailed_description>
	<mesh_term>Spondylolisthesis</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Spinal Neoplasms</mesh_term>
	<criteria>Patient degenerative disc disease , spondylolisthesis , spinal stenosis , trauma , atlantoaxial fracture instability cervical tumor . Patient operate PASS OCT® Patient &gt; 18 year Patient affiliate health care insurance ( social security France ) Patient able complete selfadministered questionnaire Patient able understand protocol plan visit Patient able sign inform consent form Patient unable unwilling sign inform consent form Patient unable complete selfadministered questionnaire Pregnant patient intend get pregnant within next 3 year Patient judge noncompliant investigator able come back followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>